Investigators assessed the factors associated with medication treatment for opioid use disorder and whether it is linked to hepatic decompensation or death in patients with cirrhosis and active opioid use disorder.
All members of the US military must get a COVID-19 vaccine by mid-September.
A team of researchers plans to test the feasibility and acceptability of cognitive behavioral therapy for veterans with insomnia and alcohol use disorder.
The researchers strove to develop and validate a computerized adaptive diagnostic (CAD) screener and computerized adaptive test (CAT) for PTSD symptom severity.
Prior to the COVID-19 pandemic, that more than 60% of US adults were lonely; these numbers only increased during the pandemic. Clinicians should focus more time on the psychological and social factors of aging to improve the quality of life of the elderly.
The researchers’ objective was to examine whether PTSD could be compared and assessed based on DSM-IV and DSM-5 criteria, using PTSD Checklists.
Has there been a silver lining during the COVID-19 pandemic? While extensive research has documented the negative psychiatric consequences of the pandemic, no study has examined whether it might be associated with positive psychological growth or posttraumatic growth, until now.
The researchers asked this question: “What is the association of combat exposure with suicide attempts among active-duty US service members who were deployed in support of the wars in Iraq and Afghanistan?”
The researchers conducted genome-wide association studies of PTSD in military veterans to explore the genetic association with the common comorbidities of depression and anxiety.
The goals of this study were to identify functional connectome fingerprints that predict symptom improvement with any treatment and with specific treatment.
